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OBJECTIVES: Women with invasive placentation (IP) are at high risk of life-threatening hemorrhage. In the last
two decades, less invasive surgical approaches combined with endovascular procedures have proven to be safe.
Most case series describe the use of temporary balloon occlusion and embolization, either combined or not.
Concerning hemorrhage rates, each separate interventional approach performs better than surgery alone does,
yet it is not clear whether the combination of multiple interventional techniques can be beneficial and promote
a lower incidence of intrapartum bleeding. We aim to evaluate whether combining temporary balloon
occlusion of the internal iliac artery and uterine artery embolization promotes better hemorrhage control than
do other individual interventional approaches reported in the scientific literature in the context of cesarean
birth followed by hysterectomy in patients with IP.
METHODS: This is a retrospective analysis of patients with confirmed IP who underwent temporary balloon
occlusion and embolization of the internal iliac arteries followed by puerperal hysterectomy. We compared
patient results to data extracted from a recent systematic review and meta-analysis of the current literature that
focused on interventional procedures in patients with IP.
RESULTS: A total of 35 patients underwent the procedure during the study period in our institution. The mean
volume of packed red blood cells and the estimated blood loss were 487.9 mL and 1193 mL, respectively. Four
patients experienced complications that were attributed to the endovascular procedure.
CONCLUSION: The combination of temporary balloon occlusion and uterine artery embolization does not seem
to promote better hemorrhage control than each procedure performed individually does.
KEYWORDS: Abnormally Invasive Placenta; High-Risk Pregnancy; Postpartum Hemorrhage; Embolization;
Placenta Accreta.
’ INTRODUCTION
Failed placental detachment is the leading cause of third
trimester bleeding and complications that lead to maternal
death (1,2). Women with invasive placentation (IP) are at high
risk of life-threatening hemorrhage, with reports of maternal
mortality as high as 7% (3,4). Although IP is a somewhat
uncommon condition (5), we have noticed a rising incidence
of IP alongside the increasing number of surgical deliveries
worldwide (6-10).
The average blood loss during birth among women with
IP is 3000-5000 mL, and thus, transfusion is required in
as many as 90% of patients (1,4,11). When facing IP, the
recommendation for primary treatment remains a planned
cesarean hysterectomy when IP is suspected prenatally (3,9).
However, there is a notable increase in the literature aiming
for uterine preservation with less invasive approaches com-
bined with endovascular procedures.
A few different interventional radiology (IR) techniques
have been reported since Dubois first reported a case series
in which balloon occlusion and embolization of the internal
iliac arteries (IIA) were used to prevent postpartum hemor-
rhage (12). Most case series describe the use of temporary
balloon occlusion of different levels of the abdominopelvicDOI: 10.6061/clinics/2019/e946
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circulation, such as the distal aorta, common iliac artery and
IIA associated or not with pelvic embolization. The results
vary between the different approaches; however, they demon-
strate that endovascular interventions have noticeable value in
reducing hemorrhage in abnormal placentation births (13).
Concerning hemorrhage rates, each interventional approach
performs better than surgery alone does, yet it is not clear
whether the combination of multiple interventional techni-
ques can be beneficial and promote reduced intrapartum
bleeding in the context of this disease.
We present a single-center retrospective study in which
temporary prophylactic balloon occlusion of the IIA followed
by bilateral uterine artery embolization (PBOIIA+UAE)
was used to aid puerperal hysterectomy aimed at reducing
bleeding and transfusion needs in patients with histopatho-
logically confirmed IP.
In this study, we aim to evaluate whether combining
temporary balloon occlusion of the IIA and embolization of
the uterine artery result in better outcomes than do other
individual interventional approaches reported in the scien-
tific literature in the context of cesarean birth followed by
hysterectomy in patients with IP.
’ MATERIALS AND METHODS
We conducted a retrospective study of all patients who
underwent PBOIIA+UAE and puerperal hysterectomy for
IP treatment from January 2012 to November 2016. The
selected patients selected were those with a high clinical
suspicion of IP and signs of IP on magnetic resonance
imaging or ultrasound. Patients without histopathologically
confirmed IP and those who did not receive embolization
were excluded from the evaluation. The obtained patient data
include a detailed gestational and previous surgical history,
a log of transfused blood products, a record of hemoglobin
levels throughout the procedure, documentation of the dura-
tion of hospital stay and details of any procedure-related
complications.
The histopathological reports were analyzed and categor-
ized according to the classical definition of IP (7). Placenta
accreta was characterized as trophoblastic invasion beyond
the decidua basalis without muscular involvement. Placenta
increta was diagnosed if there were signs of deep myometrial
invasion, and if there were signs of serosa breach, the status
of placenta percreta was assigned. The subtypes are generally
referred together as IP.
Both the endovascular and surgical procedures were
performed in the same operating room. Patients underwent
cystoscopy the day before delivery or immediately before
surgery; ureteral catheters were placed if signs of vesical or
parametrium invasion were observed or suspected. Attend-
ing anesthesiologists chose between general anesthesia or
spinal block and sedation.
We used the bilateral retrograde transfemoral approach
to place a 7-French sheath via the Seldinger technique.
Pressurized saline solution was used to continuously irrigate
both sheaths. Under fluoroscopic guidance and using anato-
mical parameters, noncompliant balloon catheters (Mustang,
Boston Scientific, Marlborough, MA, USA; Advance 35LP,
Cook Medical, Bloomington, USA) were placed in both
IIA over a 0.035-in, 260-cm angled stiff hydrophilic guide
wire (Radiofocus, Terumo, Tokyo, Japan) after selective
catheterization using a Cobra 2 5-French angiographic
catheter (Performa, Merit Medical, South Jordan, USA;
Optitorque, Terumo, Japan). Balloon catheter sizes ranged
from 20 to 40 mm in length and from 8 to 9 mm in diameter.
After balloon inflation with the minimum volume that was
sufficient to block blood flow, we performed small-volume
contrast injections through the sheaths to test and con-
firm artery occlusion (Figure 1). Cesarean delivery was
performed via the vertical abdominal incision approach.
Immediately after birth, the balloons were inflated to the
previously tested volumes. The placenta was kept in place,
the uterine wall was sutured and the ovarian anastomosis
was ligated.
The second stage of the endovascular procedure began
with acquiring a series of angiographic images of each bal-
loon catheter to assess the origin of the uterine arteries. The
same balloon catheters were used for embolization. When
the uterine artery (UA) was successfully catheterized, embo-
lic microspheres (700-900 or 900-1200 mm, Embospheres,
Biosphere Medical, Paris, France; 700 or 900 mm, Embozene,
Figure 1 - Balloon catheter placement and testing. (A) Inflated balloon catheter positioned in the left internal iliac artery.
(B) Retrograde contrast injection through the left femoral sheath confirming the correct placement of the balloon and the absence of
flow distally into the internal iliac branches.
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CeloNova BioSciences, San Antonio, TX, USA; or 700-900 or
900-1200 mm, BeadBlock, Biocompatibles, Farnham, United
Kingdom) diluted with a 50% strength iodine contrast
solution were injected under fluoroscopic guidance until
flow reduction was achieved. A mixture of 2-mm pieces of
absorbable gelatin sponge (Gelfoam, Pharmacia & Upjohn
Co., Kalamazoo, MI, USA) and 50% strength iodine contrast
was injected until the uterine arterial flow was completely
blocked. When the uterine artery was not selectively
catheterized, we first used small, 2-mm pieces of absorbable
gelatin sponge to embolize the IIA. Once flow arrest or
retardation to the muscular branches and flow redirection
to the uterine artery were observed, we used microspheres
to achieve satisfactory flow reduction of the uterine artery
and then performed embolization of the IIA with absorb-
able gelatin sponges. Embolization was considered com-
plete when flow arrest was evident with the balloons deflated
(Figure 2). Inflation of the balloons was maintained while the
obstetricians proceeded with the hysterectomy (Figure 3).
The balloons were then deflated and removed, followed by
the removal of the sheaths and manual compression of the
puncture sites.
Calculated blood loss (CBL) among patients who did not
receive transfusion products was calculated using an adap-
tation of the Meunier’s hemoglobin dilution formula (14).
Among patients who underwent transfusion, we adjusted
the hemoglobin levels to the amount of red blood cells
transfused based on findings by Elzik et al. (15).
Ethical approval
The institutional review board approved the study with a
waiver for a consent form issued by the ‘‘Comitê de Ética em
Pesquisa do Hospital das Clínicas da Faculdade de Medicina
de Ribeirão Preto da Universidade de São Paulo, Brasil’’,
under the number 1.908.096, approved on February 06, 2017.
Figure 2 - (A) Angiographic images obtained before embolization depicting the enhancement of the uterine vessels. (B) Final
angiographic results after embolization. Note the absence of enhancement in the uterine territory and the flow arrest at the left
internal iliac artery branches.
Figure 3 - (A, B) Hysterectomy specimens submitted to postoperative posterior longitudinal hysterotomy. Embolic microspheres (arrows)
deep in the placental tissue (P). Note the narrowing of the myometrium (M) in the lower uterine segment where there is contact
between the placenta and the uterine serosa (S), which is a typical characteristic of placenta percreta.
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’ RESULTS
Thirty-five patients underwent PBOIIA+UAE and puerp-
eral hysterectomy for IP treatment at our institution from
2012 to 2016 (Table 1). The mean age was 33 years old (range
24 to 43 years old). Only 3 patients did not undergo previous
cesarean sections but presented a history of uterine surgical
manipulation (uterine curettage – patient numbers 1 and 35;
myomectomy – patient number 7). Among the remaining 32
patients, the mean number of previous cesarean sections was
2.4, ranging from 1 to 4. The mean gestational age at birth
was 33 weeks and 6 days, ranging from 25 weeks and 6 days
to 38 weeks and 2 days. Histopathological reports placed
25.7% (9/35) of patients in the accreta category, 31.4% (11/35)
in the increta category and 42.8% (15/35) in the percreta
category.
The mean global CBL was 1193 mL (range 157 to 2967 mL;
SD 679 mL), with lower CBL in patients with the accreta
subtype than in patients with the increta and percreta sub-
types (Table 2). Hemoglobin levels prior to the procedures
ranged from 9.8 mg/dL to 14.3 mg/dL (mean 11.53 mg/dL).
Eighteen patients (51.4%) did not require any type of
transfusion to maintain stability. The volume of transfused
RBCs in the remaining 17 patients ranged from 278 mL to
3384 mL (mean 1004 mL; SD 738 mL).
There was no maternal mortality during the procedures or
during the follow-up period. One case of fetal death was
reported due to chromosomal disease not compatible with
extrauterine life. Hospital records revealed complications in
the cases of 9 patients (21.2%), among which only 4 cases
(11.2%) of complications were attributed to the endovascular
procedure itself. Of those, two were diagnosed with acute
arterial thrombosis, one with gluteal muscle necrosis and one
with minor subcutaneous and skin lesions. No anatomical or
technical discrepancies were identified in the patients who
experienced necrosis. In both cases, initial embolization from
the uterine arteries was performed using 700-900 mm embo-
lic microspheres, which was the most frequently utilized size
in our cohort (40% of the cases). Procedure length and CBL
were also between average, and in both cases, there were no
signs of extrauterine invasion. No additional interventions
were needed to treat the patient with skin lesions, and
follow-up revealed full recovery in three weeks. Three
patients showed signs of minor surgical wound infection,
and all of them were successfully treated with antibiotics.
Two patients underwent unilateral ureteral reconstruction,
and one patient underwent bladder reconstruction at the
time of hysterectomy. One patient presented with vaginal
bleeding secondary to a small vaginal cuff tear, which was
promptly surgically assessed and repaired.
The procedure duration was evaluated in 34 patients (one
patient was missing this information in her medical records),
and the procedure length ranged from 200 minutes to 475
minutes (average 332 minutes, SD 70 minutes), with no
significant difference among the histopathological subtypes
of IP (p=0.642). The length of hospital stay ranged from 2 to
22 days (mean 7.7 days, SD 5.3 days), with no significant
differences among the histopathological subtypes (p=0.138).
Only 10 patients stayed longer than one week, three of
whom waited for their newborns to be discharged, two
for the treatment of surgical wound infections and one for
a follow up of the ureteral reconstruction surgery. One
patient presented with signs of puerperal psychosis, and one
patient presented with psychological grieving and received
counselling that extended her hospital stay. No data are
presented regarding radiation exposure in this series of
patients.
’ DISCUSSION
Due to the recent increase in the incidence of and the
ability to prenatally diagnose IP, discussions involving
alternatives for the prevention of hemorrhage in patients
with IP have multiplied. Many IR procedures are available to
aid cesarean birth in patients with IP. Reports on prophylac-
tic balloon occlusion of the abdominal aorta (PBOAA), of the
common iliac arteries (PBOCIA) and of the internal iliac
arteries (PBOIIA) and uterine artery embolization (UAE)
followed or not by hysterectomy have been described and
shown to prevent intrapartum hemorrhage in patients with
IP when compared to hysterectomy alone (16-18). Most of
the data available come from retrospective series and few
randomized studies; thus, there are heterogeneous results
regarding the efficiency and safety of each approach.
The present series reports the use of PBOIIA+UAE and
puerperal hysterectomy for IP. Contrary to more recent
trends in publications, in which the primary aim was to
avoid hysterectomy, immediate postpartum hysterectomy
was defined as the standard of care at our institution. Data
regarding the effectiveness of PBOIIA to prevent the need for
hysterectomy remain controversial (5,19,20).
A recent systematic review published by Shahin and Pang
(13) compared 69 studies involving 1395 patients undergoing
different approaches aimed to assist birth in the context of
abnormal placentation. Our case series revealed mean blood
loss rates (1193 mL [range 157 to 2967 mL; SD 679 mL]) that
are compatible with those indicated in the previous review
(Table 3). The same review showed that in a subgroup
analysis of PBOIIA for caesarean section and caesarean
hysterectomy, only the latter had a positive impact on blood
loss. The key points revealed by Shahin and Pang’s study are
that the balloon positioning seems to have an impact on
hemorrhage control and complication rates and suggests that
positioning the balloons at the abdominal aorta might be the
most effective protection against bleeding, whereas distal
positioning of the balloon (as in PBOCIA or PBOIIA) may
increase the rates of thromboembolic complications.
During regular cesarean sections, the estimated blood loss
(EBL) is approximately 1000 mL, and a blood transfusion is
usually not required (21). Among the patients with IP, the
EBL during deliveries without the incorporation of IR
procedures to minimize bleeding varies from 3000 to 5000
mL, and transfusion is required in up to 95% of patients (4).
In deliveries assisted with IR techniques, the mean EBL
ranges from 586 to 15000 mL (13). These heterogeneous
results depend on multiple factors, for instance, whether the
placenta was left in place, if hysterectomy was performed,
variations in the degree of placental invasion and varia-
tions in experience of the multidisciplinary surgical team.
Although cesarean birth followed by hysterectomy presents
higher EBL rates than purely cesarean birth does, post-
operative bleeding complications are far more common
during conservative uterine management, affecting up to
13.5% of patients (22,23). As expected, higher bleeding
reports and transfusion needs are observed in patients with
placenta percreta and increta than in those with placenta accreta
(22). In our patient cohort, the mean CBL was 1193 mL, with
a significantly lower mean CBL in patients with the IP
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classification (706.5 mL). This number is expressively smaller
than that observed in reports of patients who underwent
hysterectomy alone (1000-4446 mL) (13).
More than half of our patients did not require transfusion,
agreeing with the results reported in Shahin and Pang’s
meta-analysis, which revealed a total of 11 studies in which
patients who underwent endovascular intervention had lower
RBC unit transfusion needs than did patients who did not
receive endovascular intervention. In our series, the average
global procedure time was 332 minutes. This considerable
procedure duration is directly related to the intent of hyste-
rectomy and the fact that the records accounted for the entire
time the patient was in the OR, including the time for placing
ureteral catheters and initiating anesthesia and not just the
time required for the interventional procedures themselves.
The balloon-related complications described in the litera-
ture vary from 3 to 50% and include groin hematoma (24-26);
fetal bradycardia (25); arterial thrombosis and limb ischemia
(17,24,27,28); and iliac dissection (27). The present series
reports complications in 11% of cases, including two cases of
femoral thromboses, one of gluteal muscular necrosis and one
of subcutaneous and skin lesions. However, Shahin and
Pang’s meta-analysis revealed a total of 16 occurrences of
lower limb arterial thromboses (1.14% of the 1485 patients
submitted to all interventions), which was significantly lower
than the incidence of lower limb arterial thromboses reported
in our series (5.7%), especially if we take into consideration
that the review accounted for studies in which large-bore
sheaths were used for the PBOAA technique. As a note, we
state that the use of angioplasty balloons, instead of typical
occlusion-type compliant balloons, is a result of the equipment
availability in our institution. The most comprehensive litera-
ture to date suggests that the arterial thrombosis complica-
tions observed in our cohort may be related to the positioning
of the balloons in the IIA. Since both hemorrhage control and
complication rates were compatible with those observed in the
literature for other techniques alone, this finding raises the
discussion of whether the use of the combined approach is
indeed beneficial, when applied distinctively in cases of low-
stage wall invasion (29,30).
Embolization-related complications vary from 8 to 36%
and include groin hematoma (31), skin necrosis (28), fetal
death (32), hematochezia (33), ovarian vein thrombosis (33),
uterine synechiae (33), endometrial atrophy (33) and endo-
metritis (34); the latter ones apply to cases in which the
uterus was left in place and is not suitable for comparison to
the cases in our study. Once again, Shahin and Pang’s meta-
analysis revealed 10 patients who underwent PBOIIA or
PBOCIA and developed intermittent lower limb or buttock
claudication but found no reports of actual necrosis in the
follow up.
The current study has a few limitations, most of which are
intrinsic to the retrospective design. Blood loss estimations
had to be calculated using an indirect method, and although
the hemoglobin dilution method is imperfect, it can be used
as an estimate (14). It is worth mentioning that the methods
used for calculating intrapartum bleeding have not been
mentioned in most papers regarding the use of IR techniques
for the treatment of IP. In our series, all procedures took
place away from the Interventional Radiology department,
using mobile C-arms at the institution’s surgical unit, where
no routine protocol to register the radiation dosages was
previously established. Although we lack radiation exposure
records, we believe that dosages did not exceed those
encountered during similarly described techniques; there-
fore, we took into consideration that the fetuses were expo-
sed to fluoroscopy only during the positioning of the balloon
catheters in both IIA and that no actual angiographic series
where performed before birth. Since all patients underwent
hysterectomy, the impact of radiation on fertility is not a
concern among this patient population.
In summary, PBOIIA+UAE followed by hysterectomy
seems to be feasible and to effectively reduce blood loss
and transfusion requirements among this specific group of
patients, yet with few remarkable contributions toward imp-
roving patient outcomes. Since the combination of the two
techniques does not seem to perform better than single-
technique approaches do, and our cohort of patients pre-
sented a higher complication rate than expected, the study
suggests that using a single interventional technique may be
Table 2 - Procedure time, blood transfusion, blood loss and hospital stay in each histological subgroup.
Histological degree Number of cases Mean procedure time* Mean blood transfusions Mean blood loss (mL) Hospital stay (days)
Accreta 9 327 min 185.9 mL/0.78 U 706.5 6.7
Increta 11 321 min 834.0 mL/3.27 U 1,398.4 5.9
Percreta 15 342 min 415.3 mL/1.67 U 1,334.4 9.7
Total 35 332 min 487.9 mL/1.94 U 1,193.0 mL 7.7
*= Time from the beginning of anesthesia to the end of the abdominal wall closure.
Table 3 - Mean cumulative blood loss volume from all endovascular procedures.*
Technique Number of studies Mean (range) cumulative blood loss in the intervention group (mL)
PBOAA 7 865.5 (613.6 to 1117.4)
PBOCIA 4 1650 (827.5 to 2473)
PBOIIA 25 1263 (95% CI 1030 to 1497.5)
PBOUA 3 1141 (265.3 to 2016.8)
UAE 7 2273.4 (980.5 to 3566.4)
Current (PBOIIA + UAE) - 1193 (157 to 2967; SD 679)
PBOAA: prophylactic balloon occlusion of the abdominal aorta; PBOCIA: prophylactic balloon occlusion of the common iliac arteries; PBOIIA: prophylactic
balloon occlusion of the internal iliac arteries; PBOUA: prophylactic balloon occlusion of the uterine arteries; UAE: uterine arteries embolization;
mL: milliliters.
* extracted and adapted from Shahin and Pang, 2018 (13).
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preferred. As expected, because most data available to date
come from small series and nonrandomized studies, the need
for prospective randomized controlled trials evaluating the
performance of all interventional techniques in patients with
IP remains.
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